Mesoblast Ltd. Files Form 6-K with Updates
Ticker: MESO · Form: 6-K · Filed: 2026-04-08T06:15:11-04:00
Sentiment: neutral
Topics: foreign-issuer, report, announcement
TL;DR
MESOBLAST LTD (MESO) filed a 6-K on 4/8/26 with press releases and graphics - check for news.
AI Summary
Mesoblast Ltd. filed a Form 6-K on April 8, 2026, reporting information as a foreign issuer. The filing includes various exhibits, such as press releases and appendices, with graphic files, indicating updates or announcements from the company. The company's mailing and business address is located at Level 38, 55 Collins Street, Melbourne, Victoria, C3 3000.
Why It Matters
This filing provides crucial updates and announcements from Mesoblast Ltd., which could impact investors' understanding of the company's current status and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign issuer and does not contain specific financial results or significant corporate actions that would inherently increase risk.
Key Players & Entities
- MESOBLAST LTD (company) — Filer of the 6-K report
- 0001345099 (company) — CIK number for MESOBLAST LTD
- 2026-04-08 (date) — Filing date and period of report
- Melbourne, Victoria (location) — Company's business and mailing address
FAQ
What type of form is this 6-K filing?
This is a Form 6-K, which is a Report of foreign issuer pursuant to Rules 13a-16 and 15d-16.
When was this 6-K filing accepted by the SEC?
The filing was accepted on 2026-04-08 at 06:15:11.
What is the CIK number for MESOBLAST LTD?
The CIK number for MESOBLAST LTD is 0001345099.
Where is MESOBLAST LTD's business address?
MESOBLAST LTD's business address is LEVEL 38, 55 COLLINS STREET, MELBOURNE, VICTORIA, C3 3000.
What is the SIC code listed for MESOBLAST LTD?
The SIC code listed is 2836 for Biological Products, (No Diagnostic Substances).
From the Filing
EDGAR Filing Documents for 0001345099-26-000039 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: SEC Accession No. 0001345099-26-000039 Filing Date 2026-04-08 Accepted 2026-04-08 06:15:11 Documents 14 Period of Report 2026-04-08 Document Format Files Seq Description Document Type Size 1 6-K form6-kxpressreleasecoverf.htm 6-K 17823 2 EX-99.1 exhibit991chymalappendix.htm EX-99.1 1880 3 EX-99.2 exhibit992chymalappendix.htm EX-99.2 2185 4 exhibit991chymalappendix001.jpg GRAPHIC 68694 5 exhibit991chymalappendix002.jpg GRAPHIC 100665 6 exhibit991chymalappendix003.jpg GRAPHIC 111418 7 exhibit991chymalappendix004.jpg GRAPHIC 160472 8 exhibit991chymalappendix005.jpg GRAPHIC 32279 9 exhibit992chymalappendix001.jpg GRAPHIC 71888 10 exhibit992chymalappendix002.jpg GRAPHIC 57952 11 exhibit992chymalappendix003.jpg GRAPHIC 66170 12 exhibit992chymalappendix004.jpg GRAPHIC 78641 13 exhibit992chymalappendix005.jpg GRAPHIC 72419 14 exhibit992chymalappendix006.jpg GRAPHIC 96084 Complete submission text file 0001345099-26-000039.txt 1286162 Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036 MESOBLAST LTD (Filer) CIK : 0001345099 (see all company filings) EIN. : 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630 Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 26846437 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)